Approval of an Additional Endometriosis Indication for Relumina
A regulatory milestone for the individual product Relumina Tablets 40 mg, which received approval for the additional indication of endometriosis, expanding its approved uses.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.